Found: 59
Select item for more details and to access through your institution.
A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 1, p. 97, doi. 10.3892/ijo.2015.2978
- By:
- Publication type:
- Article
Notice of erratum.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan.
- Published in:
- Journal of Gastroenterology, 2008, v. 43, n. 11, p. 842, doi. 10.1007/s00535-008-2242-1
- By:
- Publication type:
- Article
Longitudinal investigation of a xenograft tumor zebrafish model using polarization-sensitive optical coherence tomography.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-19483-z
- By:
- Publication type:
- Article
High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.
- Published in:
- International Immunology, 2012, v. 24, n. 8, p. 477, doi. 10.1093/intimm/dxs048
- By:
- Publication type:
- Article
Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 4, p. 322, doi. 10.1111/ajco.12094
- By:
- Publication type:
- Article
How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 129, doi. 10.1111/j.1743-7563.2011.01385.x
- By:
- Publication type:
- Article
A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0333-8
- By:
- Publication type:
- Article
A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 452, doi. 10.1186/s13014-015-0333-8
- By:
- Publication type:
- Article
Detection of circulating tumor cells in patients with lung cancer using a rare cell sorter: a pilot study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12945-9
- By:
- Publication type:
- Article
Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4862, doi. 10.3390/cancers13194862
- By:
- Publication type:
- Article
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2947, doi. 10.3390/cancers12102947
- By:
- Publication type:
- Article
Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients.
- Published in:
- Surgery Today, 2011, v. 41, n. 8, p. 1067, doi. 10.1007/s00595-010-4432-8
- By:
- Publication type:
- Article
Chemotherapy for small-bowel Adenocarcinoma at a single institution.
- Published in:
- Surgery Today, 2009, v. 39, n. 1, p. 27, doi. 10.1007/s00595-008-3843-2
- By:
- Publication type:
- Article
Enhancement of vascular smooth muscle cell migration by urotensin II.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, v. 373, n. 5, p. 381, doi. 10.1007/s00210-006-0086-x
- By:
- Publication type:
- Article
Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0239439
- By:
- Publication type:
- Article
Soluble PD‐L1 predicts tumor response and immune‐related adverse events in patients with advanced melanoma treated with anti–PD‐1 antibodies.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 807, doi. 10.1111/1346-8138.17183
- By:
- Publication type:
- Article
Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
- Published in:
- Pathology & Oncology Research, 2017, v. 23, n. 4, p. 737, doi. 10.1007/s12253-016-0175-1
- By:
- Publication type:
- Article
Upregulation of Enzymes Metabolizing 5-Fluorouracil in Colorectal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2007, v. 53, n. 1, p. 36, doi. 10.1159/000098249
- By:
- Publication type:
- Article
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 6, p. 1295, doi. 10.3892/mco.2015.630
- By:
- Publication type:
- Article
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 1053, doi. 10.3892/mco.2015.602
- By:
- Publication type:
- Article
Secondary central nervous system lymphoma surrounding a region injured by subarachnoid hemorrhage and subsequent aneurysmal clipping.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Clinical Outcome of Biliary Drainage for Obstructive Jaundice Caused by Colorectal and Gastric Cancers.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 12, p. 1161, doi. 10.1093/jjco/hys168
- By:
- Publication type:
- Article
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 763, doi. 10.1007/s00280-010-1543-2
- By:
- Publication type:
- Article
Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 6, p. 1222, doi. 10.1002/ijc.30810
- By:
- Publication type:
- Article
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 803, doi. 10.1002/ijc.30106
- By:
- Publication type:
- Article
Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 3099, doi. 10.2147/DDDT.S85567
- By:
- Publication type:
- Article
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 1653, doi. 10.2147/DDDT.S80449
- By:
- Publication type:
- Article
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06).
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 421, doi. 10.1007/s10120-017-0766-x
- By:
- Publication type:
- Article
A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 2, p. 350, doi. 10.1007/s10120-016-0614-4
- By:
- Publication type:
- Article
Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 839, doi. 10.1007/s10120-015-0518-8
- By:
- Publication type:
- Article
Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 2, p. 625, doi. 10.1007/s10120-015-0517-9
- By:
- Publication type:
- Article
Plasma Exchange May Enhance Antitumor Effects by Removal of Soluble Programmed Death-Ligand 1 and Extracellular Vesicles: Preliminary Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102483
- By:
- Publication type:
- Article
Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 11, p. 1898, doi. 10.1002/cncr.29259
- By:
- Publication type:
- Article
Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 17, p. 4026, doi. 10.1002/cncr.25977
- By:
- Publication type:
- Article
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 3329, doi. 10.2147/OTT.S89241
- By:
- Publication type:
- Article
Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 2005, doi. 10.2147/OTT.S87101
- By:
- Publication type:
- Article
Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01).
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1111, doi. 10.2147/OTT.S83952
- By:
- Publication type:
- Article
Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 529, doi. 10.2147/OTT.S77190
- By:
- Publication type:
- Article
Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 243, doi. 10.2147/OTT.S75722
- By:
- Publication type:
- Article
Author Correction: A practical guide to intelligent image-activated cell sorting.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
A practical guide to intelligent image-activated cell sorting.
- Published in:
- Nature Protocols, 2019, v. 14, n. 8, p. 2370, doi. 10.1038/s41596-019-0183-1
- By:
- Publication type:
- Article
5-Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells
- Published in:
- FEBS Letters, 2005, v. 579, n. 30, p. 6721, doi. 10.1016/j.febslet.2005.10.068
- By:
- Publication type:
- Article
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib.
- Published in:
- Cancer Science, 2020, v. 111, n. 2, p. 441, doi. 10.1111/cas.14273
- By:
- Publication type:
- Article